The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p deletion. Andrew Schorr interviewed CLL expert Dr. Thomas Kipps to get his perspective on what this new approval means for patients.
Breaking News: Expert Perspective on V... - CLL America Support
Breaking News: Expert Perspective on Venclexta (venetoclax) Approval
Written by
mcints
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Good News from the Doctor Venetoclax is working!
I started my Venetoclax journey September 7th. A few bumps on the way up from 20mgs. to 400 mgs....
I’m unclear what to think of my diagnosis
I’m new here and not clear about the diagnosis given on my Flow Cytometry, which classified me with...
Choice of doctors
Ok so I've got a real dilemma. I'm on W&W. I have two top CLL specialists in two sister hospitals....
Hubby about to begin Obinutuzumab infusions....feeling anxious
Aloha! My husband (age 74) was diagnosed with CLL back in 2003 and had eighteen years of zero...
My Cll progression
Hi have been on wait and watch since 1908 my WBC has increased and platelet count is dropping....
Treatmant for cll
CLL diagnosis and diet
I'm new to the site
